Showing 1081-1090 of 1319 results for "".
Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/The Multiple Sclerosis Lesion Checklist
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-lesion-checklist/30216/A clinician's guide to evaluating brain MRI in a patient with improbable multiple sclerosis.Cluster Headache and Other Trigeminal Autonomic Cephalalgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-and-other-trigeminal-autonomic-cephalalgias/32001/Accurate and timely classification of cluster headache vs other TACs can help speed time to relief and remission in those with headache pain.Dementia Insights: Cognitive Consequences of Perimenopause
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-cognitive-consequences-ofperimenopause/31525/A possible contribution of perimenopause should be considered when evaluating women with cognitive complaints.Mental Health and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/Assessing and addressing mental health in patients and care partners improves quality of life.About the Cover Artist: Le Bon, La Brute, Et Le Truand by JJ Ignatius Brennan
https://practicalneurology.com/diseases-diagnoses/headache-pain/about-the-cover-artist-ile-bon-la-brute-et-le-truandi-by-jj-ignatius-brennan/32137/The artwork of JJ Ignatius Brennan is informed by the visual disturbances and auras he experiences during migraine attacks.Helping Make the Invisible, Visible: Plasma Biomarker Testing for the Evaluation of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/helping-make-the-invisible-visible-plasma-biomarker-testing-for-the-evaluation-of-traumatic-brain-injury/32107/This article discusses the availability of rapid plasma biomarker testing for TBI and its implications in clinical care.Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Multiple Sclerosis in the Hispanic/Latinx Population
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-hispaniclatinx-population/31757/Hispanic/Latinx individuals with MS are a diverse group for whom genetic and environmental factors affect prevalence, disease course, and treatment that varies by region.Early Clinically Unsuspected Alzheimer’s Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/early-clinically-unsuspectedalzheimers-disease/31566/Biomarkers can be important tools for diagnosis.